Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.99NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XBF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.343NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.310NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Y.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.154NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.137NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.446NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.76 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.398NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.163NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.3 (Theta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.213NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.56 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.91.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AY.4.14 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BN.1.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.485NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.112.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.8 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used